Assessment of risk factors for the development of simple and complex non-atypical endometrial hyperplasia


  • N. A. Bykova
Keywords: risk factors, simple non-atypical endometrial hyperplasia, complex non-atypical endometrial hyperplasia, diagnosis.

Abstract

Annotation. Goal – to identify and assess the most significant risk factors for the development of simple non-atypical endometrial hyperplasia (SNAEH) and complex non-atypical endometrial hyperplasia (CNAEH) in women. Retrospective analysis of anamnestic data of 58 case histories of patients with SNAEH, 35 case histories of patients with CNAEH and data of 30 women of the control group, which allowed to identify risk factors for hyperproliferative processes of the endometrium (HPE) for research, the statistical significance of which was further assessed by calculating odds ratio (OR). The main feature associated with the risk of SNAEH is heredity – OR = 49.73 (95% CI 2.90–852.32). Significantly increases the risk of developing SNAEH in the presence of thyroid gland lesion (TGL) – OR = 34.97 (95% CI 2.03–601.20). The third in the hierarchical sequence is the polycystic ovary syndrome factor; OR = 25.72 (95% CI 1.488–444.59). Heredity occupies the top of the hierarchical structure in the group of patients with CNAEH. OR is 80.67 (95% CI 4.56–1424.76). A high probability of developing CNAEH is also observed for women over the age of 50 (OR = 32.44 (95% CI 1.82–576.56). In third place – the presence of TGL, which significantly increases the risk of developing CNAEH; OR = 28.63 (95% CI 1.60–510.56) Identification of statistically significant risk factors for the development of HPE will help to identify risk groups among the population, to carry out preventive measures among them (lifestyle adjustments, treatment of concomitant diseases) and decrease the incidence of the HPE.

References

1. Vlasov, R. S. (2011). Klinicheskoe znachenie metilirovaniya genov-supressorov opuholevogo rosta pri patologicheskih protsessah endometriya u jenschin reproduktivnogo vozrasta [Clinical significance of methylation of tumor suppressor genes in pathological processes of the endometrium in women of reproductive age]. (Dis. kand. med. nauk). Pervyiy MGMU im. I.M. Sechenova, Moskva. Vzyato s http://medical-diss.com/medicina/klinicheskoe-znachenie-metilirovaniya-genov-supressorov-opuholevogo-rosta-pri-patologicheskih-protsessah-endometriya-u-zh

2. Vovk, I. B., Gorban, N. E., & Borisyuk, O. YU. (2016). Giperplaziya endometriya (klinicheskaya lektsiya) [Endometrial hyperplasia (clinical lecture)]. Zdorove jenschinyi – Women's health, 5, 10–18. Vzyato s http://nbuv.gov.ua/UJRN/Zdzh_2016_5_3

3. Kornienko, S. M. (2017). Giperplasticheskie protsessyi endometriya u jenschin v pozdnem reproduktivnom i premenopauzalnom periode: chto vliyaet na retsidivyi [Hyperplastic processes of the endometrium in women in the late reproductive and premenopausal period: what affects relapses]. Вісник соціальної гігієни та організації охорони здоров’я України – Bulletin of social hygiene and health care organization of Ukraine, 2, 39–47. Vzyato s http://nbuv.gov.ua/UJRN/VSG_2017_2_9

4. Tatarchuk, T. F., & Kalugina, L. V. (2012). K voprosu o lechenii giperplazii endometriya [On the treatment of endometrial hyperplasia]. Reproduktivnaya endokrinologiya – Reproductive endocrinology, 4, 88–92. DOI: https://doi.org/10.18370/2309-4117.2012.4.88-93

5. Tatarchuk, T. F., Kalugina, L. V., & Tutchenko, T. N. (2015). Giperplasticheskie protsessyi endometriya: chto novogo? [Endometrial hyperplastic processes: what's new?]. Reproduktivnaya endokrinologiya – Reproductive endocrinology, 5 (25), 7–13. DOI: http://dx.doi.org/10.18370/2309-4117.2015.25.7-13

6. Tkachenko, L. V., & Sviridova, N. I. (2013). Prognosticheskie faktoryi riska razvitiya giperplasticheskih protsesov endometriya v perimenopauzalnom periode [Predictive risk factors for the development of endometrial hyperplastic processes in the perimenopausal period]. Volgogradskiy nauchno-meditsinskiy jurnal – Volgograd Medical Scientific Journal, 4, 43–47. Vzyato s https://cyberleninka.ru/article/n/prognosticheskie-faktory-riska-razvitiya-giperplasticheskih-protsessov-endometriya-v-perimenopauzalnom-periode

7. Unanyan, A. L., Sidorova, I. S., Kogan, E. A., & Baburin, D. V. (2018). Kliniko-patogeneticheskie osobennosti giperplasticheskih protsessov endometriya u jenschin perimenopauzalnogo vozrasta [Clinical and pathogenetic features of endometrial hyperplastic processes in women of perimenopausal age]. RMJ “Meditsinskoe obozrenie” – RMJ “Medical Review”, 1 (I), 67–71. Vzyato s https://www.rusmedreview.com/articles/ginekologiya/Kliniko-patogeneticheskie_osobennosti_giperplasticheskih_processov_endometriya_ughenschin_perimenopauzalynogo_vozrasta/

8. Fedorenko, Z. P., Hulak, L. O., Mykhailovych, Yu. Y., Horokh, Ye. L., Ryzhov, A. Yu, Sumkina, O. V., & Kutsenko, L. B. (2020). Rak v Ukraini, 2018–2019: zakhvoriuvanist, smertnist, pokaznyky diialnosti onkolohichnoi sluzhby [Cancer in Ukraine, 2018–2019: morbidity, mortality, indicators of oncology service activity]. Biuleten nats. kantser-reiestru Ukrainy – Bulletin of the National Cancer Registry of Ukraine, 21. Vziato z http://www.ncru.inf.ua/publications/BULL_21/index.htm

9. Clark, T. J., Neelakantan, D., & Gupta, J. K. (2006). The management of endometrial hyperplasia: an evaluation of current practice. Eur. J. Obstet. Gynecol. Reprod. Biol., 125 (2), 259–264. doi: 10.1016/j.ejogrb.2005.09.004

10. Senechal, C., Cottereau, E., de Pauw, A., Elan, C., Dagousset, I., & Fourchotte, V. (2015). Environmental and genetic risk factors for endometrial carcinoma. Bull Cancer, 102 (3), 256–69. doi: 10.1016/j.bulcan.2015.01.006

11. Trimble, C. L., Method, M., Leitao, M., Lu, K., Ioffe, O., Hampton, M., … & Mutter, G. L. (2012).  Management of endometrial precancers. Obstet. Gynecol., 120 (5), 1160–1175. doi: 10.1097/aog.0b013e31826bb121
Published
2020-12-28
How to Cite
Bykova, N. A. (2020). Assessment of risk factors for the development of simple and complex non-atypical endometrial hyperplasia. Reports of Vinnytsia National Medical University, 24(4), 584-588. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2020-24(4)-04